Moonlake Immunotherapeutics Ag
Moonlake Immunotherapeutics Ag is a Private limited company (Ltd.) registered in Switzerland under CHE433093536, and its current status with Zefix — Swiss Central Business Names Index is active. The company was incorporated on 10 March 2021 and lists its registered address as Zug, Switzerland. 4 shareholders are on record for Moonlake Immunotherapeutics Ag, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Zefix — Swiss Central Business Names Index and was last updated on 28 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
4
Four shareholders are currently on record for Moonlake Immunotherapeutics Ag, reflecting the Aktienbuch (share register) maintained under Article 686 of the Swiss Code of Obligations rather than a public filing.
The largest of these is VANGUARD WORLD FUND-Vanguard Health Care Index Fund, holding 0.3% — the largest recorded stake — followed by iShares Trust-iShares ESG Aware MSCI USA Small-Cap ETF at 0.2%; the remaining 2 shareholders shown hold smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| VANGUARD WORLD FUND-Vanguard Health Care Index Fund | 0.3% | Zefix — Swiss Central Business Names Index | |
| iShares Trust-iShares ESG Aware MSCI USA Small-Cap ETF | 0.2% | Zefix — Swiss Central Business Names Index | |
| JNL Series Trust-JNL MULTI-MANAGER SMALL CAP VALUE FUND | 0.2% | Zefix — Swiss Central Business Names Index | |
| T. ROWE PRICE Eqy. SERIES, INC.-T. Rowe Price Health Sciences PORT. | 0.1% | Zefix — Swiss Central Business Names Index |
Officers
5
The Co-founder, Ceo & Director of Moonlake Immunotherapeutics Ag currently on record is Jorge Santos Da Silva; five officers are currently on record for Moonlake Immunotherapeutics Ag, filed with Zefix — Swiss Central Business Names Index.
The register reports 17 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Moonlake Immunotherapeutics Ag sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Moonlake Immunotherapeutics Ag sits 1 level below its ultimate parent, Moonlake Immunotherapeutics, registered in Cayman Islands. 2 subsidiaries are recorded beneath it, across 3 jurisdictions. The full chain up to Moonlake Immunotherapeutics is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Moonlake Immunotherapeutics Ag's own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 2 subsidiaries span Switzerland, Portugal, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Moonlake Immunotherapeutics
Cayman Islands
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Moonlake Immunotherapeutics Ag?
Four shareholders are currently on record for Moonlake Immunotherapeutics Ag, reflecting the Aktienbuch (share register) maintained under Article 686 of the Swiss Code of Obligations rather than a public filing. The largest of these is VANGUARD WORLD FUND-Vanguard Health Care Index Fund, holding 0.3% — the largest recorded stake — followed by iShares Trust-iShares ESG Aware MSCI USA Small-Cap ETF at 0.2%; the remaining 2 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Moonlake Immunotherapeutics Ag's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Moonlake Immunotherapeutics Ag is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Moonlake Immunotherapeutics Ag have on record?
4 shareholders are shown on record for Moonlake Immunotherapeutics Ag.
What is Moonlake Immunotherapeutics Ag's company registration number?
Moonlake Immunotherapeutics Ag's registration number is CHE433093536, filed with Zefix — Swiss Central Business Names Index in Switzerland. Its current status on the register is active.
Is Moonlake Immunotherapeutics Ag still an active company?
Moonlake Immunotherapeutics Ag's status on Zefix — Swiss Central Business Names Index is listed as active.
When was Moonlake Immunotherapeutics Ag incorporated?
Moonlake Immunotherapeutics Ag was incorporated on 10 March 2021, according to Zefix — Swiss Central Business Names Index.
What is Moonlake Immunotherapeutics Ag's registered address?
The registered address on file for Moonlake Immunotherapeutics Ag is Zug, Switzerland.
What legal structure is Moonlake Immunotherapeutics Ag registered as?
Moonlake Immunotherapeutics Ag is registered as a Private limited company (Ltd.) in Switzerland.
Who are the officers/directors of Moonlake Immunotherapeutics Ag?
The Co-founder, Ceo & Director of Moonlake Immunotherapeutics Ag currently on record is Jorge Santos Da Silva; five officers are currently on record for Moonlake Immunotherapeutics Ag, filed with Zefix — Swiss Central Business Names Index. Management authority at Moonlake Immunotherapeutics Ag sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Moonlake Immunotherapeutics Ag have a parent company or subsidiaries?
Moonlake Immunotherapeutics Ag sits 1 level below its ultimate parent, Moonlake Immunotherapeutics, registered in Cayman Islands. 2 subsidiaries are recorded beneath it, across 3 jurisdictions. Those 2 subsidiaries span Switzerland, Portugal, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to Moonlake Immunotherapeutics Ag's ownership over time?
This profile reflects a point-in-time snapshot from Zefix — Swiss Central Business Names Index. Zavia's monitoring API can track changes to Moonlake Immunotherapeutics Ag's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Moonlake Immunotherapeutics Ag's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Switzerland, so records like Moonlake Immunotherapeutics Ag's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Zefix — Swiss Central Business Names Index and was last synced on 28 September 2026.